B-Cell lymphoproliferative syndrome and peripheral blood CD20+ cells expansion after hematopoietic stem cell transplantation: association with fludarabine and anti-thymocyte globulin containing conditioning regimen-Reference-Cited by-同舟云学术

B-Cell lymphoproliferative syndrome and peripheral blood CD20+ cells expansion after hematopoietic stem cell transplantation: association with fludarabine and anti-thymocyte globulin containing conditioning regimen

Published:2003-12 Issue:8 Volume:35 Page:3093-3095
ISSN:0041-1345
Container-title:Transplantation Proceedings
language:en
Short-container-title:Transplantation Proceedings

Author:

Lange A,Klimczak A,Dlubek D,Dybko J

Publisher

Elsevier BV

Subject

Transplantation,Surgery

Reference5 articles.

1. Malignancies after hematopoietic stem cell transplantation;Deeg;Blood,1998

2. Risk of lymphoproliferative disorders after bone marrow transplantation;Curtis;Blood,1999

3. Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell-depleted SCT;Van Esser;Blood,2001

4. Posttransplantation lymphoproliferative disorders in bone marrow transplant recipients are aggressive diseases with a high incidence of adverse histologic and immunobiologic features;Orazi;Am J Clin Pathol,1997

5. Epstein-Barr virus infections in bone marrow transplantation recipients;Gratama,1994

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validation of a Post-Transplant Lymphoproliferative Disorder Risk Prediction Score and Derivation of a New Prediction Score Using a National Bone Marrow Transplant Registry Database;The Oncologist;2021-09-23

2. Post Transplant Lymphoproliferative Disorder;Indian Journal of Hematology and Blood Transfusion;2019-09-17

3. Risk factors and clinical outcomes of Epstein–Barr virus DNAemia and post-transplant lymphoproliferative disorders after haploidentical and matched-sibling PBSCT in patients with hematologic malignancies;Annals of Hematology;2019-06-26

4. Frequency, characteristics, and outcome of PTLD after allo-SCT: A multicenter study from the Spanish group of blood and marrow transplantation (GETH);European Journal of Haematology;2019-04-10

5. Risk factors, diagnosis, and management of posttransplant lymphoproliferative disorder: improving patient outcomes with a multidisciplinary treatment approach;Transplant Research and Risk Management;2017-01